Gennaro Pagano
15PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Aug 13, 2025
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.Gennaro Pagano, Dylan Trundell, Tanya Simuni
|Jul 02, 2025
Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.Gennaro Pagano, Dylan Trundell, Tanya Simuni
|Nov 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approaches.Amit Khanna, Jamie Adams, Chrystalina Antoniades
|Oct 08, 2024
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.Gennaro Pagano, Annabelle Monnet, Adriana Reyes
|Sep 27, 2024
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.Tien Dam, Gennaro Pagano, Michael C Brumm
|Sep 24, 2024
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts.Tien Dam, Gennaro Pagano, Michael C Brumm
Pageof 3
Frequent Collaborators
3 joint publications
Hanno Svoboda
3 joint publications
Andrew Siderowf
2 joint publications
Kalpana Merchant
2 joint publications
Heather Wilson
2 joint publications
Kathrin Brockmann
2 joint publications
Tanya Simuni
2 joint publications
Tatiana Foroud
2 joint publications
Kathleen L Poston
2 joint publications
Daniel Weintraub
2 joint publications
Luis Concha-Marambio
